MX2021005582A - Formulaciones de terapias contra la gripe. - Google Patents

Formulaciones de terapias contra la gripe.

Info

Publication number
MX2021005582A
MX2021005582A MX2021005582A MX2021005582A MX2021005582A MX 2021005582 A MX2021005582 A MX 2021005582A MX 2021005582 A MX2021005582 A MX 2021005582A MX 2021005582 A MX2021005582 A MX 2021005582A MX 2021005582 A MX2021005582 A MX 2021005582A
Authority
MX
Mexico
Prior art keywords
formulations
influenza therapeutics
influenza
therapeutics
compositions
Prior art date
Application number
MX2021005582A
Other languages
English (en)
Inventor
Liang Mao
Irina C Jacobson
Sam Sk Lee
Tianjing Zhao
Original Assignee
Cocrystal Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cocrystal Pharma Inc filed Critical Cocrystal Pharma Inc
Publication of MX2021005582A publication Critical patent/MX2021005582A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

En el presente documento se proporcionan composiciones de un agente terapéutico antivírico para tratar la gripe, adecuadas para la administración por inhalación.
MX2021005582A 2018-11-13 2019-11-13 Formulaciones de terapias contra la gripe. MX2021005582A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862760121P 2018-11-13 2018-11-13
PCT/US2019/061065 WO2020102270A1 (en) 2018-11-13 2019-11-13 Formulations of influenza therapeutics

Publications (1)

Publication Number Publication Date
MX2021005582A true MX2021005582A (es) 2021-06-30

Family

ID=68835306

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005582A MX2021005582A (es) 2018-11-13 2019-11-13 Formulaciones de terapias contra la gripe.

Country Status (13)

Country Link
US (1) US20210393629A1 (es)
EP (1) EP3880251A1 (es)
JP (1) JP2022513035A (es)
KR (1) KR20210091753A (es)
CN (1) CN113164612A (es)
AU (1) AU2019380421A1 (es)
BR (1) BR112021009254A2 (es)
CA (1) CA3119145A1 (es)
EA (1) EA202191327A1 (es)
IL (1) IL283005A (es)
MX (1) MX2021005582A (es)
TW (1) TW202031293A (es)
WO (1) WO2020102270A1 (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
US4353656A (en) 1980-10-14 1982-10-12 Xerox Corporation Moving coil, multiple energy print hammer system including a closed loop servo
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
CA1224992A (en) 1982-10-08 1987-08-04 Robert E. Newell Device for administering medicament to patients
FI88112C (fi) 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6632666B2 (en) 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
TWI491416B (zh) * 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
KR20160084465A (ko) * 2013-11-13 2016-07-13 버텍스 파마슈티칼스 인코포레이티드 아자인돌 화합물의 제형
EP3068776B1 (en) * 2013-11-13 2019-05-29 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
RU2745071C2 (ru) * 2015-12-15 2021-03-18 Сионоги Энд Ко., Лтд. Лекарственный препарат для лечения гриппа, характеризующийся тем, что в нем объединены ингибитор кэп-зависимой эндонуклеазы и лекарственное средство против гриппа
EA039181B1 (ru) * 2017-04-24 2021-12-15 Кокристал Фарма, Инк. Производные пирролопиримидина, пригодные в качестве ингибиторов репликации вируса гриппа

Also Published As

Publication number Publication date
US20210393629A1 (en) 2021-12-23
EP3880251A1 (en) 2021-09-22
CA3119145A1 (en) 2020-05-22
EA202191327A1 (ru) 2021-08-09
WO2020102270A1 (en) 2020-05-22
JP2022513035A (ja) 2022-02-07
IL283005A (en) 2021-06-30
CN113164612A (zh) 2021-07-23
KR20210091753A (ko) 2021-07-22
BR112021009254A2 (pt) 2021-08-10
WO2020102270A8 (en) 2021-06-03
AU2019380421A1 (en) 2021-06-03
TW202031293A (zh) 2020-09-01

Similar Documents

Publication Publication Date Title
PH12018500904A1 (en) Peptide macrocycles against acinetobacter baumannii
MX2019012676A (es) Derivados de 2-aminoquinolina.
MX2018002301A (es) Composiciones de glucano y usos de las mismas.
TN2018000043A1 (en) Novel 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitors
SV2017005557A (es) Derivados de indol mono o disustituidos como inhibidores de la replicacion viral del dengue
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12020550341A1 (en) Niraparib formulations
MX2018005729A (es) Composiciones terapeuticas para tratamiento del virus de inmunodeficiencia humana.
MX2019002438A (es) Compuestos triciclicos fusionados de piridazinona utiles para tratar infecciones de orthomyxovirus.
MX2018000419A (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor.
MX2022005775A (es) Compuestos terapeuticos y metodos de uso.
PH12019500569A1 (en) Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
CL2017002299A1 (es) Combinaciones de dosis fija y formulaciones comprendiendo etc-1002 y ezetimiba y métodos para tratar o reducir el riesgo de enfermedades cardiovasculares
PH12021550443A1 (en) Pyridazinones and methods of use thereof
GEP20207096B (en) Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anti-cancer ingredient, pharmaceutical com¬position, medicinal prepara¬tion, method for treating prostate cancer
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
CY1120602T1 (el) [1,2,4]τριαζολο[4,3-β]πυριδαζινες για χρηση στη θεραπευτικη αντιμετωπιση πολλαπλασιαστικων ασθενειων
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
MX2018000611A (es) Sistemas mejorados de entrega de nanoparticula.
MX2021004860A (es) Piridazinas novedosas.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
MX2021006993A (es) Analogos de nucleosidos de ciclopentilo como antivirales.
MX2021005582A (es) Formulaciones de terapias contra la gripe.
CO2018011797A2 (es) Derivados de tetrahidropirano y tiopirano que tienen actividad multimodal contra el dolor
EA201990834A1 (ru) Пиримидиновые пролекарства для лечения вирусных инфекций и других заболеваний